ArticleDermatology and therapy2024

Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World Study.

Sofía Haselgruber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.